Cmpx stock forecast.

The Compass Therapeutics, Inc. stock price gained 6.00% on the last trading day (Friday, 17th Nov 2023), rising from $1.50 to $1.59. During the last trading day the stock fluctuated 15.61% from a day low at $1.51 to a day high of $1.74. The price has fallen in 6 of the last 10 days and is down by -14.52% for this period.Compound Price Live Data. The live Compound price today is $51.45 USD with a 24-hour trading volume of $77,211,369 USD. We update our COMP to USD price in real-time. Compound is up 1.11% in the last 24 hours. The current CoinMarketCap ranking is #107, with a live market cap of $412,787,173 USD. It has a circulating supply of 8,023,528 …Dec 1, 2023 · Price Target Upside/Downside. According to analysts' consensus price target of $9.33, Compass Therapeutics has a forecasted upside of 465.2% from its current price of $1.65. Amount of Analyst Coverage. Compass Therapeutics has received no research coverage in the past 90 days. 2 days ago · Analyst Forecast. According to 4 analysts, the average rating for CMPX stock is "Strong Buy." The 12-month stock price forecast is $9.33, which is an increase of 452.07% from the latest price. Step 1: Check Ratings History. In the short term, look to see whether analysts suggest an initiation, upgrade or downgrade for a particular stock. Understand how the rating changed compared to the ...

We’ve all flipped between different weather apps, wondering why each is giving a slightly different report. Before we look at AccuWeather, it’s important to understand the basics of weather forecasting. In the past, weather predictions were...Source: YCharts. Management said during the company's 2022 investor day in June last year that it expects long-term annual revenue growth of 20%. Assuming AMD's top line grows at an annual pace of ...

Stock analysis for Compass Therapeutics Inc (CMPX:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.Prev Close 2.81. 52 Week High 5.65. 52 Week High Date 12/23/22. 52 Week Low 1.30. 52 Week Low Date 05/04/22. Market Cap 380.788M. Shares Out 126.51M. 10 Day Average Volume 0.28M. Dividend -.

Nov 24, 2023 · View Compass Therapeutics, Inc CMPX investment & stock information. Get the latest Compass Therapeutics, Inc CMPX detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Track COMPASS Pathways (CMPS) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsAccording to the issued ratings of 6 analysts in the last year, the consensus rating for Mesoblast stock is Hold based on the current 1 sell rating, 3 hold ratings and 2 buy ratings for MESO. The average twelve-month price prediction for Mesoblast is $7.13 with a high price target of $17.00 and a low price target of $1.50.Based on short-term price targets offered by seven analysts, the average price target for Compass Therapeutics, Inc. comes to $9.33. The forecasts range from a low of $8.00 to a high of $11.00 ... Find the latest Capital Power Corporation (CPX.TO) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W ...

According to . 1 Wall Street analyst that have issued a 1 year PSTV price target, the average PSTV price target is $8.00, with the highest PSTV stock price forecast at $8.00 and the lowest PSTV stock price forecast at $8.00.

Data Link's cloud-based technology platform allows you to search, discover and access data and analytics for seamless integration via cloud APIs. Register for your free account today at data ...

View the full NASDAQ Composite Index (COMP.US) index overview including the latest stock market news, data and trading information.Find the latest Capital Power Corporation (CPX.TO) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W ...The U.S. National Weather Service (NWS) is a part of the National Oceanic and Atmospheric Administration (NOAA). Many people rely on the National Weather Service’s forecasts in order to better anticipate what the weather will be like so the...According to the National Snow & Ice Data Center, blizzard prediction relies on modeling weather systems, as well as predicting temperatures. The heavy snowfall that blizzards create can be hard to predict in advance.CMPX Stock Forecast 2023. Compass Therapeutics boasts a robust drug pipeline, which explains why analysts are bullish on the stock. The Phase 2 and Phase 3 studies for cancer drug CTX-009 extend into H2 2023, at which time the company plans to initiate a Phase 1 study for its CTX-8371 drug also for cancer after filing an Investigational New Drug Application (IND) earlier in 2023.

March 7, 2024. EPS forecast (this quarter) $0.30. Annual revenue (last year) $378.5M. Annual profit (last year) $18.7M. Net profit margin.Compass Therapeutics (CMPX) Stock Forecast & Price Prediction. Estimation of the future price movement of Compass Therapeutics stock, based on various factors such as historical price trends, market trends, company performance, and economic conditions.Predicting the weather has long been one of life’s great mysteries — at least for regular folks. Over the years, you’ve probably encountered a few older adults — maybe even your own grandparents — who made some weather predictions based on ...Website. 2014. 26. Tom Schuetz. https://www.compasstherapeutics.com. Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company’s product candidates include CTX-009, a bispecific antibody that blocks Delta …Stock Price Forecast. The 5 analysts offering 12-month price forecasts for CompoSecure Inc have a median target of 13.00, with a high estimate of 15.00 and a low estimate of 7.00. The median ...

Find the latest Compass Therapeutics, Inc. (CMPX) stock forecast, 12-month price target, predictions and analyst recommendations.

I am 57 and have $1.1 million in my 401(k) and $50,000 in a high-yield savings account. I earn $300,000 per year and put $30,000 in my 401(k) each year plus a match on the first 6%.In this article, we answer “what is sales forecasting?” by breaking down its objectives, owners, methods, and best practices. Sales | What is REVIEWED BY: Jess Pingrey Jess served on the founding team of a successful B2B startup and has use...Typically, the average forecast for the group predicts the S&P 500 climbing by about 10%, which is in line with historical averages. 14h ago The Wall Street JournalThe stock has increased 17.9% in price over the past month and closed Friday’s trading session at $3.03. Each of the four Wall Street analysts that rated ELEV rated it Buy. The 12-month median price target of $11.50 indicates a 279.5% potential upside. The price targets range from a low of $11.00 to a high of $12.00.Find the latest Capital Power Corporation (CPXWF) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W ...Lastly, it’s important to evaluate a stock by comparing it against others in the same industry. Review the table below to see how Compass Therapeutics Inc. stock stands up against its competitors. Click into any of the below tickers to see their stock grades for value, momentum, quality and EPS revisions. Compass Therapeutics Inc. (CMPX ...Average target price for CMPX - Compass TherapeuticsCommon Stock is predicted at $3.336 within next 1 year. Stock Screener App. Free - Install ☾ Dark EN. Sign in. Watchlist; Top Lists; Visualized Report New; Options; Industries; Elite; Market Simulator; Stock Calculator; Dow: 34,512.00 (+0.02%) 34,512.00 (+6.001)Compass Therapeutics Stock (NASDAQ: CMPX) stock price, news, charts, stock research, profile. ... Dow Drops 100 Points; Verizon Issues Weak Earnings Forecast. Lisa Levin - Jan 24, ...Being prepared to weather a hurricane — whether that involves fortifying your home or creating an emergency evacuation plan — is an important part of making it through the storm. Hurricanes travel across the ocean via massive, circular gust...

Latest CMPS News. View. COMPASS Pathways (CMPS, $5.98) entered Downtrend as Momentum indicator drops below 0 level on Nov 30, 2023. Tickeron - Stocks • 3 days ago. Compass Pathways to participate in upcoming Evercore investor conference. Globe Newswire • 10 days ago.

Get the latest Cerner Corporation (CERN) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals.

BOSTON, Aug. 30, 2023 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced that the Company will participate in the following investor events during the month of September 2023. Prev Close 2.81. 52 Week High 5.65. 52 Week High Date 12/23/22. 52 Week Low 1.30. 52 Week Low Date 05/04/22. Market Cap 380.788M. Shares Out 126.51M. 10 Day Average Volume 0.28M. Dividend -.Their AMPX share price targets range from $10.00 to $14.00. On average, they anticipate the company's stock price to reach $12.33 in the next twelve months. This suggests a possible upside of 173.5% from the stock's current price. View analysts price targets for AMPX or view top-rated stocks among Wall Street analysts.Track COMPASS Pathways (CMPS) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors In this article, we answer “what is sales forecasting?” by breaking down its objectives, owners, methods, and best practices. Sales | What is REVIEWED BY: Jess Pingrey Jess served on the founding team of a successful B2B startup and has use...Looking ahead, revenue is forecast to grow 2.2% p.a. on average during the next 3 years, compared to a 4.6% growth forecast for the Metals and Mining industry in …The Compass Therapeutics stock forecast for tomorrow is $ 1.516608, which would represent a -1.52% loss compared to the current price. In the next week, the price of CMPX is expected to decrease by -2.77% and hit $ 1.497361. As far as the long-term Compass Therapeutics stock forecast is ... Compass Therapeutics Stock (NASDAQ: CMPX) stock price, news, charts, stock research, profile. ... Dow Drops 100 Points; Verizon Issues Weak Earnings Forecast. Lisa Levin - Jan 24, ...According to . 1 Wall Street analyst that have issued a 1 year PSTV price target, the average PSTV price target is $8.00, with the highest PSTV stock price forecast at $8.00 and the lowest PSTV stock price forecast at $8.00.18 brokerages have issued 1-year price objectives for ChargePoint's shares. Their CHPT share price targets range from $2.00 to $17.00. On average, they expect the company's share price to reach $9.13 in the next year. This suggests a possible upside of 380.1% from the stock's current price.

500. Check out the ideas and forecasts on stocks from top authors of our community. They share predictions and technical outlook of the market to find trending stocks of different countries: India, USA, UK, Japan, etc. Join our financial community to start learning more about the markets. — India.See CAPITAL POWER CORPORATION stock price prediction for 1 year made by analysts and compare it to price changes over time to develop a better trading strategy. ... Forecast . Price target. 44.85 0.00 0.00%. The 10 analysts offering 1 year price forecasts for CPX have a max estimate of — and a min estimate of —.APRE Stock 12 Months Forecast. $15.00. (300.00% Upside) Based on 3 Wall Street analysts offering 12 month price targets for Aprea Therapeutics in the last 3 months. The average price target is $15.00 with a high forecast of $20.00 and a low forecast of $9.00. The average price target represents a 300.00% change from the last price of $3.75.Instagram:https://instagram. apple iphone 15 pro stockstocks insiders are buying nowaston martin aston martin dbsnas investments portfolio The average one-year price target for CMPX / Compass Therapeutics Inc is $9.35. The forecasts range from a low of $8.08 to a high of $11.55. A stock’s price target is the price at which analysts consider it fairly valued with respect to …The average twelve-month price prediction for Compass Therapeutics is $9.33 with a high price target of $10.30 and a low price target of $8.00. Learn more on CMPX's analyst rating history. Do Wall Street analysts like Compass Therapeutics more than its competitors? forex brokers for us clientsvision plans texas Dec 1, 2023 · When is Compass Therapeutics's earnings date? Compass Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 20th, 2024 based off last year's report dates. Learn more on CMPX's earnings history. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of ... best options trading account Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET.Find the latest Immunovant, Inc. (IMVT) stock quote, history, news and other vital information to help you with your stock trading and investing.Total current assets stand at $120.231 million, much more than the total amount of liabilities. With notes receivable worth $18.7 million and goodwill of $23.742 million, CompX reported total ...